<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (MDSs) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> characterized by ineffective hematopoiesis, enhanced bone marrow <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and frequent progression to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Several recent studies suggested that, besides the abnormal development of stem cells, microenvironmental alterations are also present in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we have examined the relative frequencies of stem and progenitor cell subsets of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic cells growing on stromal cell layers established from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients and from <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="3" pm="."><plain>When hematopoietic cells from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were co-cultured with <z:mpath ids='MPATH_458'>normal</z:mpath> stromal cells, the frequency of either early or late cobblestone area-forming cells (CAFC) was significantly lower compared to the corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> control values in 4 out of 8 patients </plain></SENT>
<SENT sid="4" pm="."><plain>In the opposite situation, when <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic cells were incubated on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stromal cells, the CAFC frequencies were decreased in 5 out of 6 patients, compared to <z:mpath ids='MPATH_458'>normal</z:mpath> stromal layer-containing control cultures </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, a soluble Notch ligand (Jagged-1 protein) was an inhibitor of day-35-42 CAFC when <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic cells were cultured with <z:mpath ids='MPATH_458'>normal</z:mpath> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stromal cells, but was unable to inhibit <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stem and early progenitor cell growth (day-35-42 CAFC) on pre-established stromal layers </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that in early hematopoietic cells isolated from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients the Notch signal transduction pathway is disrupted </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, there was a marked reduction in the plasticity of mesenchymal stem cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients compared with those of <z:mpath ids='MPATH_458'>normal</z:mpath> marrow donors, in neurogenic and adipogenic differentiation ability and hematopoiesis supporting capacity in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>These results are consistent with the hypothesis that when alterations are present in the myelodysplastic stroma environment along with intrinsic changes in a hematopoietic stem/progenitor cell clone, both factors might equally contribute to the <z:mp ids='MP_0002123'>abnormal hematopoiesis</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>